• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

推出全新慢性阻塞性肺疾病袖珍咨询指南应用程序:数字方法能否改善护理?慢性阻塞性肺疾病基金会声明。

Introducing the New COPD Pocket Consultant Guide App: Can A Digital Approach Improve Care? A Statement of the COPD Foundation.

作者信息

Thomashow Byron, Crapo James D, Drummond M Bradley, Han MeiLan K, Kalhan Ravi, Malanga Elisha, Malanga Vinny, Mannino David M, Rennard Stephen, Sciurba Frank C, Willard Kristen S, Wise Robert, Yawn Barbara

机构信息

Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University, New York.

Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, Colorado.

出版信息

Chronic Obstr Pulm Dis. 2019 Jul 24;6(3):210-220. doi: 10.15326/jcopdf.6.3.2018.0167.

DOI:10.15326/jcopdf.6.3.2018.0167
PMID:31075813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6872221/
Abstract

The COPD Foundation has tried to address gaps in chronic obstructive pulmonary disease (COPD) care by providing COPD Pocket Consultant Guide cards to U.S. health care providers. Since launching the card in 2007, there have been numerous updates and more than 800,000 of these cards have been distributed at no charge to health care professionals. The most recent versions have concentrated on presenting an algorithm for COPD management based on 7 severity domains: spirometry, symptoms, exacerbations, oxygen requirements, the presence of chronic bronchitis or emphysema and comorbidities. To increase the usability and reach of this tool, the COPD Pocket Consultant Guide is now available as an app for iOS and Android. This updated version of the app includes new COPD and asthma/COPD overlap flow charts; an interactive therapy chart that takes into account modified Medical Research Council (mMRC), COPD Assessment Test (CAT), and spirometry scores; anxiety and depression screeners; up-to-date medication charts in both brand and generic formats; a checklist to aid in determining when a patient should be referred to a pulmonologist and more. Potential use of the COPD Pocket Consultant Guide app in clinical care is discussed.

摘要

慢性阻塞性肺疾病(COPD)基金会通过向美国医疗服务提供者提供COPD袖珍咨询指南卡片,试图填补慢性阻塞性肺疾病护理方面的空白。自2007年推出该卡片以来,已进行了多次更新,超过80万张此类卡片已免费分发给医疗专业人员。最新版本集中于呈现一种基于7个严重程度领域的COPD管理算法:肺功能测定、症状、急性加重、氧需求、慢性支气管炎或肺气肿的存在以及合并症。为了提高该工具的可用性和覆盖面,COPD袖珍咨询指南现在可作为适用于iOS和安卓系统的应用程序使用。该应用程序的更新版本包括新的COPD和哮喘/COPD重叠流程图;一个交互式治疗图表,该图表考虑了改良的医学研究委员会(mMRC)、COPD评估测试(CAT)和肺功能测定分数;焦虑和抑郁筛查工具;品牌和通用格式的最新药物图表;一个有助于确定患者何时应转诊至肺科医生的检查表等。文中还讨论了COPD袖珍咨询指南应用程序在临床护理中的潜在用途。

相似文献

1
Introducing the New COPD Pocket Consultant Guide App: Can A Digital Approach Improve Care? A Statement of the COPD Foundation.推出全新慢性阻塞性肺疾病袖珍咨询指南应用程序:数字方法能否改善护理?慢性阻塞性肺疾病基金会声明。
Chronic Obstr Pulm Dis. 2019 Jul 24;6(3):210-220. doi: 10.15326/jcopdf.6.3.2018.0167.
2
The COPD Foundation Pocket Consultant Guide.慢性阻塞性肺疾病基金会袖珍咨询指南
Chronic Obstr Pulm Dis. 2014 May 6;1(1):83-87. doi: 10.15326/jcopdf.1.1.2014.0124.
3
The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide.慢性阻塞性肺疾病基金会《慢性阻塞性肺疾病袖珍咨询指南》2017年更新版
Chronic Obstr Pulm Dis. 2017 Jul 15;4(3):177-185. doi: 10.15326/jcopdf.4.3.2017.0136.
4
Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, recommendations of the COPD Foundation.介绍 COPD 基金会 COPD 诊断和管理指南,这是 COPD 基金会的建议。
COPD. 2013 Jun;10(3):378-89. doi: 10.3109/15412555.2013.801309.
5
GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.慢性阻塞性肺疾病的GOLD分类:症状与急性加重风险评估标准中的不一致性
COPD. 2017 Feb;14(1):1-6. doi: 10.1080/15412555.2016.1230844. Epub 2016 Oct 10.
6
Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.在社区药房环境中,自我报告患有 COPD 的个体的症状负担和呼吸药物依从性评估。
J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4):479-488.e1. doi: 10.1016/j.japh.2019.04.017. Epub 2019 May 22.
7
Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.将新的慢性阻塞性肺疾病(COPD)全球倡议(GOLD)分期系统应用于美国基层医疗队列,并与医生和患者对严重程度的印象进行比较。
Int J Chron Obstruct Pulmon Dis. 2015 Jul 30;10:1477-86. doi: 10.2147/COPD.S78827. eCollection 2015.
8
COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.在Humana医疗保险成员中,慢性阻塞性肺疾病(COPD)急性加重与改良的医学研究委员会量表及COPD评估测试的相关性。
Int J Chron Obstruct Pulmon Dis. 2016 Jan 14;11:111-21. doi: 10.2147/COPD.S94323. eCollection 2016.
9
Comparison of symptom and risk assessment methods among patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者症状与风险评估方法的比较
Chin Med J (Engl). 2014;127(14):2594-8.
10
Recent updates in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的最新进展
Postgrad Med. 2016;128(2):231-8. doi: 10.1080/00325481.2016.1118352. Epub 2015 Dec 1.

引用本文的文献

1
Optimizing Treatment for Hospitalized Patients with COPD: A Study on the Impact of a LINE App-Based Multidisciplinary Team Approach Targeting Pharmacological Treatment, Lifestyle Changes, and Smoking Cessation.优化慢性阻塞性肺疾病住院患者的治疗:一项关于基于LINE应用程序的多学科团队方法对药物治疗、生活方式改变和戒烟影响的研究
Int J Chron Obstruct Pulmon Dis. 2025 Apr 18;20:1149-1159. doi: 10.2147/COPD.S511869. eCollection 2025.
2
Self-Management Programs and the Pursuit of Behavior Change.自我管理计划与行为改变的追求。
Respir Care. 2024 May 28;69(6):678-685. doi: 10.4187/respcare.11987.
3
Features and characteristics of publicly available mHealth apps for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的公开可用移动健康应用程序的特点与特性。
Digit Health. 2023 Apr 12;9:20552076231167007. doi: 10.1177/20552076231167007. eCollection 2023 Jan-Dec.
4
Does Evaluation and Management of COPD Follow Therapeutic Strategy Recommendations?慢性阻塞性肺疾病(COPD)的评估与管理是否遵循治疗策略建议?
Chronic Obstr Pulm Dis. 2021 Apr 27;8(2):230-242. doi: 10.15326/jcopdf.2020.0175.
5
New Adopters of Telemedicine During the Coronavirus-19 Pandemic in Respondents to an Online Community Survey: The Case for Access to Remote Management Tools for Individuals with Chronic Obstructive Pulmonary Disease.在线社区调查受访者中在冠状病毒病 2019 大流行期间采用远程医疗的新用户:为慢性阻塞性肺疾病患者提供远程管理工具的理由。
Chronic Obstr Pulm Dis. 2021 Apr 27;8(2):213-218. doi: 10.15326/jcopdf.2020.0181.
6
Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.慢性阻塞性肺疾病评估测试的临床开发与研究应用
Am J Respir Crit Care Med. 2020 May 1;201(9):1058-1067. doi: 10.1164/rccm.201907-1369PP.

本文引用的文献

1
Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.慢性阻塞性肺疾病患者的长期三联疗法降级至茚达特罗/格隆溴铵(SUNSET):一项随机、双盲、三盲临床试验。
Am J Respir Crit Care Med. 2018 Aug 1;198(3):329-339. doi: 10.1164/rccm.201803-0405OC.
2
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.COPD 患者每日一次单吸入器三联与双联治疗。
N Engl J Med. 2018 May 3;378(18):1671-1680. doi: 10.1056/NEJMoa1713901. Epub 2018 Apr 18.
3
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.特布他林、布地奈德/福莫特罗和茚达特罗/格隆溴铵治疗慢性阻塞性肺疾病(TRIBUTE)的随机对照双盲平行分组研究
Lancet. 2018 Mar 17;391(10125):1076-1084. doi: 10.1016/S0140-6736(18)30206-X. Epub 2018 Feb 9.
4
Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.嗜酸性粒细胞在慢性阻塞性肺疾病气道炎症中的作用。
Int J Chron Obstruct Pulmon Dis. 2018 Jan 17;13:335-349. doi: 10.2147/COPD.S152291. eCollection 2018.
5
The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide.慢性阻塞性肺疾病基金会《慢性阻塞性肺疾病袖珍咨询指南》2017年更新版
Chronic Obstr Pulm Dis. 2017 Jul 15;4(3):177-185. doi: 10.15326/jcopdf.4.3.2017.0136.
6
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.一项针对中度低氧慢性阻塞性肺疾病患者长期吸氧的随机试验。
N Engl J Med. 2016 Oct 27;375(17):1617-1627. doi: 10.1056/NEJMoa1604344.
7
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.茚达特罗格隆溴铵与沙美特罗氟替卡松治疗 COPD。
N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15.
8
Effectiveness of Interventions to Teach Metered-Dose and Diskus Inhaler Techniques. A Randomized Trial.定量气雾剂和都保吸入器技术教学干预措施的有效性:一项随机试验
Ann Am Thorac Soc. 2016 Jun;13(6):816-24. doi: 10.1513/AnnalsATS.201509-603OC.
9
Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort.美国人群慢性阻塞性肺疾病队列横断面研究中血嗜酸性粒细胞与临床特征的关系
Respir Med. 2016 Mar;112:88-96. doi: 10.1016/j.rmed.2016.01.013. Epub 2016 Jan 22.
10
The Asthma-COPD Overlap Syndrome.哮喘-慢阻肺重叠综合征。
N Engl J Med. 2015 Sep 24;373(13):1241-9. doi: 10.1056/NEJMra1411863.